Vietnam MOH registration 230000022/PCBA-LA

SPEROKID Nasal Spray

VN: Xịt mũi sinh học SPEROKID

Vietnam·Risk Class TTBYT Loại A·03/SPEROKID·Pharmaceutical Company of Vietnam (Đông Dược Việt)·Registered Apr 04, 2023

Registration details

Analysis ID: 230000022/PCBA-LA
Submission ID: 000.00.17.H39-230329-0001
Product Type: 03/SPEROKID

Company information

Manufacturer: Pharmaceutical Company of Vietnam (Đông Dược Việt)
Manufacturer Country: VIET NAM

Technical details

Intended Use: - Enhancing natural immunity against the invasion of respiratory viruses, including flu, respiratory syncytial virus (RSV), Coronavirus, and Rhinovirus - Support for the treatment, prevention, and improvement of respiratory viral infections - Support for the regulation of reduced inflammatory response in the respiratory tract, including asthma-related inflammation - Reduction of flu symptoms (cough, fever, sore throat) - Reduction of nasal allergy symptoms - Support for enhancing the antigenic response to the Coronavirus vaccine

Dates and status

Registration Date: Apr 04, 2023

About this record

Access comprehensive regulatory information for SPEROKID Nasal Spray in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 230000022/PCBA-LA and manufactured by Pharmaceutical Company of Vietnam (Đông Dược Việt).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.